Patrick Collins Selected Research

Patrick Collins Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 03/2016
3	Human Influenza (Influenza) 08/2011 - 03/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 12/2021
2	Fibrosis (Cirrhosis) 01/2016 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 01/2016
2	Atherosclerosis 07/2002 - 07/2002
1	Carcinogenesis 01/2022
1	Bites and Stings (Sting) 01/2022
1	Alcoholic Fatty Liver 12/2021
1	Obesity 12/2021
1	Cytokine Release Syndrome 11/2021
1	COVID-19 01/2021
1	Lymphadenopathy 12/2020
1	Adenocarcinoma 08/2020
1	Breast Neoplasms (Breast Cancer) 08/2020
1	Down Syndrome (Down's Syndrome) 08/2020
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 08/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2020
1	Scabies (Sarcoptic Mange) 08/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017
1	Starvation 01/2017
1	Disease Progression 03/2016
1	Thrombosis (Thrombus) 01/2011
1	Vascular Diseases (Vascular Disease) 04/2009
1	Hypertension (High Blood Pressure) 04/2009
1	Intermittent Claudication 07/2006
1	Inflammation (Inflammations) 07/2006
1	Atherosclerotic Plaque (Atheroma) 07/2005
1	Schizophrenia (Dementia Praecox) 02/2003
1	Dyslipidemias (Dyslipidemia) 07/2002

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2017 - 07/2002
2	Polysaccharides (Glycans)IBA 01/2016 - 01/2016
2	Galectin 3 (LGALS3)IBA 01/2016 - 01/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 02/2003
2	HomocysteineIBA 01/2011 - 04/2009
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Caspase 8 (Caspase-8)IBA 01/2022
1	CytokinesIBA 01/2022
1	AntigensIBA 01/2022
1	LigandsIBA 01/2022
1	Dual Specificity Phosphatase 3IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Oxygen (Dioxygen)IBA 08/2020
1	InterleukinsIBA 08/2020
1	Methotrexate (Mexate)FDA LinkGeneric 08/2020
1	risankizumabIBA 08/2020
1	SolutionsIBA 08/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 03/2016
1	AsparagineIBA 03/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Galectin 1 (LGALS1)IBA 01/2016
1	coumarinIBA 01/2016
1	pirfenidoneIBA 01/2016
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2016
1	Hemagglutinins (Hemagglutinin)IBA 08/2011
1	Neutralizing AntibodiesIBA 08/2011
1	IntegrinsIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	Cell Adhesion MoleculesIBA 01/2011
1	Aspartic Acid (Aspartate)FDA Link 07/2010
1	Neuraminidase (Sialidase)IBA 07/2010
1	Oseltamivir (Tamiflu)FDA Link 03/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2010
1	antineoplaston A10 (A 10)IBA 03/2010
1	Apolipoproteins B (ApoB)IBA 04/2009
1	Triglycerides (Triacylglycerol)IBA 04/2009
1	ApoproteinsIBA 04/2009
1	LDL CholesterolIBA 04/2009
1	HDL CholesterolIBA 04/2009
1	CholesterolIBA 04/2009
1	Cholesterol Ester Transfer ProteinsIBA 06/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2006
1	CollagenIBA 07/2005
1	oxidized low density lipoproteinIBA 07/2005
1	Proteoglycans (Proteoglycan)IBA 07/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2003
1	Insulin (Novolin)FDA Link 02/2003
1	Glucose (Dextrose)FDA LinkGeneric 02/2003
1	ChylomicronsIBA 07/2002
1	Messenger RNA (mRNA)IBA 07/2002
1	Apolipoproteins E (ApoE)IBA 07/2002
1	microsomal triglyceride transfer proteinIBA 07/2002

Therapy/Procedure

4	Therapeutics 06/2022 - 07/2006
1	Immunotherapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021
1	Drug Therapy (Chemotherapy) 12/2020
1	Topical Administration 08/2020
1	Condoms (Condom) 01/2017
1	Oral Administration 01/2016